ArticleNeuro-oncology2024

MGMT promoter methylation and survival following chemotherapy for WHO grade 4 IDH-mutant astrocytoma.

Mary Jane Lim-Fat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.